Schwameis, Michael <br/><br/>
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.  [electronic resource] 

 -  The Lancet. Infectious diseases  03 2017 
 - 322-329 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(16)30529-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Anti-Bacterial Agents--therapeutic use<br/>Antibiotic Prophylaxis<br/>Azithromycin--adverse effects<br/>Borrelia burgdorferi--immunology<br/>Double-Blind Method<br/>Female<br/>Germany<br/>Humans<br/>Lyme Disease--drug therapy<br/>Male<br/>Middle Aged<br/>Ticks<br/>Treatment Failure